Active ingredient
Furosemide
218 finished FDA listings contain Furosemide as their only active ingredient.
FDA NDC Directory
- Ingredient names as written by FDA
- FUROSEMIDE
- Dosage forms
- Injection, Injection, Solution, Solution, Tablet
- Routes
- Intramuscular, Intravenous, Oral, Subcutaneous
- Manufacturers / labelers
- 63
- Strengths listed
- 10 mg/ml · 100 mg/10ml · 20 mg/1 · 20 mg/2ml · 30 mg/ml · 40 mg/1 · 40 mg/4ml · 40 mg/5ml · 8 mg/ml · 80 mg/1 · 80 mg/ml
- Brand names in FDA listings
- Furoscix, Lasix, Lasix Onyu
RxNorm (National Library of Medicine)
Ingredient concept RxCUI 4603
Drugs@FDA applications
Linked only where the FDA listing’s application number matches Drugs@FDA exactly. A listing in the NDC Directory does not by itself mean FDA approval.
| Application | Sponsor | Original approval | Listings |
|---|---|---|---|
| NDA 016273 | VALIDUS PHARMS | 1966-07-01 | 3 |
| NDA 018267 | HIKMA | 1981-05-19 | 7 |
| NDA 018569 | EPIC PHARMA LLC | 1981-10-19 | 6 |
| NDA 018667 | HOSPIRA | 1982-05-28 | 8 |
| NDA 018823 | HIKMA | 1983-11-10 | 8 |
| NDA 018413 | CHARTWELL RX | 1983-11-30 | 2 |
| NDA 018902 | FRESENIUS KABI USA | 1984-05-22 | 8 |
| ANDA 070086 | HIKMA | 1986-01-24 | 2 |
| ANDA 070017 | ACCORD HLTHCARE | 1986-12-15 | 4 |
| ANDA 070433 | HIKMA | 1987-04-22 | 3 |
| ANDA 070434 | HIKMA | 1987-04-22 | 3 |
| ANDA 076796 | PRINSTON INC | 2004-03-26 | 41 |
| ANDA 077293 | LEADING | 2005-11-09 | 35 |
| ANDA 078010 | IPCA LABS LTD | 2006-09-18 | 11 |
| ANDA 202747 | BAXTER HLTHCARE CORP | 2014-01-27 | 13 |
| ANDA 203428 | AVET LIFESCIENCES | 2014-08-26 | 13 |
| ANDA 207552 | AMNEAL PHARMS CO | 2016-07-20 | 2 |
| ANDA 212174 | EUGIA PHARMA | 2019-05-03 | 5 |
| ANDA 213902 | GLAND | 2020-07-01 | 4 |
| ANDA 214766 | SAGENT | 2021-01-27 | 1 |
| ANDA 212803 | MEITHEAL | 2022-01-27 | 2 |
| NDA 209988 | SCPHARMACEUTICALS | 2022-10-07 | 2 |
| ANDA 216629 | GRAVITI PHARMS | 2022-10-17 | 19 |
| ANDA 216860 | MANKIND PHARMA | 2022-12-16 | 3 |
| ANDA 215856 | SABA ILAC SANAYIVE | 2024-04-02 | 3 |
| ANDA 217557 | ASPIRO | 2024-12-13 | 3 |
| ANDA 218831 | AUROBINDO PHARMA LTD | 2025-07-17 | 3 |
| NDA 217294 | SQ INNOVATION | 2025-10-07 | 1 |
| ANDA 218188 | MICRO LABS | 2026-01-08 | 3 |
Official labeling on DailyMed
- FUROSEMIDE TABLET [REMEDYREPACK INC.] · version 8 · 2026-08-19
- FUROSEMIDE INJECTION, SOLUTION [MEDICAL PURCHASING SOLUTIONS, LLC] · version 1 · 2026-08-13
- FUROSEMIDE TABLET [REDPHARM DRUG] · version 1 · 2026-08-13
- FUROSCIX (FUROSEMIDE) INJECTION FUROSCIX (FUROSEMIDE INJECTION 80 MG/ 10 ML) INJECTION [SCPHARMACEUTICALS INC., A WHOLLY OWNED SUBSIDIARY OF MANNKIND CORPORATION] · version 20 · 2026-08-03
- FUROSEMIDE INJECTION [CIVICA, INC.] · version 2 · 2026-07-30
- FUROSEMIDE (FUROSEMIDE) TABLET [REMEDYREPACK INC.] · version 6 · 2026-07-27
- FUROSEMIDE TABLET [REMEDYREPACK INC.] · version 14 · 2026-07-16
- FUROSEMIDE TABLET [CARDINAL HEALTH 107, LLC] · version 4 · 2026-07-01
- FUROSEMIDE TABLET [ST. MARY'S MEDICAL PARK PHARMACY] · version 3 · 2026-07-01
- FUROSEMIDE SOLUTION [ATLANTIC BIOLOGICALS CORP.] · version 1 · 2026-06-29
- FUROSEMIDE (FUROSEMIDE) TABLET [REMEDYREPACK INC.] · version 28 · 2026-06-26
- FUROSEMIDE INJECTION, SOLUTION [HF ACQUISITION CO LLC, DBA HEALTHFIRST] · version 7 · 2026-06-25
Showing the 12 most recent of 148 labels.
Sources: FDA NDC Directory (2026-09-29), RxNorm, Drugs@FDA, DailyMed. Each source’s facts are shown separately as published.